In chronic lymphocytic leukemia, it has been observed that the constitutive release of soluble BAFF and APRIL increased upon engagement of CD40 on microvascular ECs by CD40L aberrantly expressed on tumor cells. The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.